Dr. Foster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4440 W 95th Street
Oak Lawn, IL 60453- Is this information wrong?
Education & Training
- University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2016 - 2020
- University of ChicagoMS, Public Health Sciences, 2018 - 2019
- Christiana Care Health ServicesInternship, Transitional Year, 2015 - 2016
- University of Michigan Medical SchoolDoctor of Medicine, Cum Laude, 2011 - 2015
- DeSales UniversityBS, Biology, Summa Cum Laude, 2011 - 2015
- University of Michigan Medical SchoolClass of 2015
Certifications & Licensure
- IL State Medical License 2021 - 2026
- TN State Medical License 2020 - 2023
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society 2014
Clinical Trials
Publications & Presentations
PubMed
- Reply to "Guarantee-time bias in studies on the relationship between immune-related adverse events and antitumor activity".Corey C Foster, Tanguy Y Seiwert> ;Cancer. 2022 Jul 1
- 9 citationsRisk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.Ari Rosenberg, Nishant Agrawal, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair, John F. Cursio, Aditya Juloori, Daniel Thomas Ginat, Adam Howard, Jeffrey Chin, Sa...> ;Oral Oncology. 2021 Oct 18
- 27 citationsImmune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving i...Corey C. Foster, Marcus Couey, Sara Kochanny, Arun Khattri, Rajesh Acharya, Yi-Hung Carol Tan, Ryan J. Brisson, Rom Leidner, Tanguy Y. Seiwert> ;Cancer. 2021 Sep 21
- Join now to see all
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Lectures
- Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Authored Content
- Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer9/1/2017
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- Advocate Christ Medical CenterOak Lawn, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: